DOCSLIB.ORG

National Model EMS Clinical Guidelines

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Model EMS Clinical Guidelines National Model EMS Clinical Guidelines September 2017 VERSION 2.0 These guidelines will be maintained by NASEMSO to facilitate the creation of state and local EMS system clinical guidelines, protocols or operating procedures. System medical directors and other leaders are invited to harvest content as will be useful. These guidelines are either evidence-based or consensus- based and have been formatted for use by field EMS professionals. NASEMSO Medical Directors Council www.nasemso.org Contents INTRODUCTION .................................................................................................................................5 PURPOSE AND NOTES ........................................................................................................................6 TARGET AUDIENCE ......................................................................................................................................... 7 NEW IN THE 2017 EDITION ............................................................................................................................. 7 ACKNOWLEDGEMENTS ................................................................................................................................... 7 UNIVERSAL CARE ...............................................................................................................................8 UNIVERSAL CARE GUIDELINE ........................................................................................................................... 8 FUNCTIONAL NEEDS ..................................................................................................................................... 16 PATIENT REFUSALS ...................................................................................................................................... 20 CARDIOVASCULAR ........................................................................................................................... 23 ADULT AND PEDIATRIC SYNCOPE AND PRESYNCOPE ........................................................................................... 23 CHEST PAIN/ACUTE CORONARY SYNDROME (ACS)/ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) ..... 27 BRADYCARDIA ............................................................................................................................................. 30 IMPLANTABLE VENTRICULAR ASSIST DEVICES ................................................................................................... 34 TACHYCARDIA WITH A PULSE ......................................................................................................................... 37 SUSPECTED STROKE/TRANSIENT ISCHEMIC ATTACK ........................................................................................... 43 GENERAL MEDICAL........................................................................................................................... 46 ABDOMINAL PAIN ........................................................................................................................................ 46 ABUSE AND MALTREATMENT......................................................................................................................... 49 AGITATED OR VIOLENT PATIENT/BEHAVIORAL EMERGENCY ................................................................................ 53 ANAPHYLAXIS AND ALLERGIC REACTION .......................................................................................................... 59 ALTERED MENTAL STATUS ............................................................................................................................ 64 BACK PAIN ................................................................................................................................................. 67 END-OF-LIFE CARE/PALLIATIVE CARE .............................................................................................................. 70 HYPERGLYCEMIA ......................................................................................................................................... 73 HYPOGLYCEMIA ........................................................................................................................................... 76 NAUSEA-VOMITING ..................................................................................................................................... 80 PAIN MANAGEMENT .................................................................................................................................... 83 SEIZURES .................................................................................................................................................... 90 SHOCK ....................................................................................................................................................... 95 SICKLE CELL PAIN CRISIS ............................................................................................................................. 101 RESUSCITATION ............................................................................................................................. 104 CARDIAC ARREST (VF/VT/ASYSTOLE/PEA) ................................................................................................... 104 ADULT POST-ROSC (RETURN OF SPONTANEOUS CIRCULATION) CARE ............................................................... 113 DETERMINATION OF DEATH/WITHHOLDING RESUSCITATIVE EFFORTS ................................................................ 116 DO NOT RESUSCITATE STATUS/ADVANCE DIRECTIVES/HEALTHCARE POWER OF ATTORNEY (POA) STATUS ............. 119 TERMINATION OF RESUSCITATIVE EFFORTS .................................................................................................... 122 PEDIATRIC-SPECIFIC GUIDELINES .................................................................................................... 127 BRIEF RESOLVED UNEXPLAINED EVENT (BRUE) .............................................................................................. 127 PEDIATRIC RESPIRATORY DISTRESS (BRONCHIOLITIS) ....................................................................................... 132 PEDIATRIC RESPIRATORY DISTRESS (CROUP) .................................................................................................. 137 NEONATAL RESUSCITATION ......................................................................................................................... 141 Updated October 4, 2017 2 OB/GYN ......................................................................................................................................... 145 CHILDBIRTH .............................................................................................................................................. 145 ECLAMPSIA/PRE-ECLAMPSIA ....................................................................................................................... 149 OBSTETRICAL AND GYNECOLOGICAL CONDITIONS ........................................................................................... 153 RESPIRATORY ................................................................................................................................ 156 AIRWAY MANAGEMENT ............................................................................................................................. 156 BRONCHOSPASM (DUE TO ASTHMA AND OBSTRUCTIVE LUNG DISEASE) .............................................................. 166 PULMONARY EDEMA .................................................................................................................................. 173 TRAUMA ........................................................................................................................................ 177 GENERAL TRAUMA MANAGEMENT ............................................................................................................... 177 BLAST INJURIES ......................................................................................................................................... 183 BURNS ..................................................................................................................................................... 187 CRUSH INJURY ........................................................................................................................................... 191 EXTREMITY TRAUMA/EXTERNAL HEMORRHAGE MANAGEMENT ........................................................................ 194 FACIAL/DENTAL TRAUMA ........................................................................................................................... 199 HEAD INJURY ............................................................................................................................................ 202 HIGH THREAT CONSIDERATIONS/ACTIVE SHOOTER SCENARIO ........................................................................... 207 SPINAL CARE ............................................................................................................................................. 210 TOXINS AND ENVIRONMENTAL ...................................................................................................... 217 POISONING/OVERDOSE UNIVERSAL CARE ...................................................................................................... 217 ACETYLCHOLINESTERASE INHIBITORS (CARBAMATES, NERVE AGENTS, ORGANOPHOSPHATES) EXPOSURE
Load more

Recommended publications
  • Prevention and Management of Heat-Related Illness
    PREVENTION AND MANAGEMENT OF HEAT-RELATED ILLNESS Federal Bureau of Prisons Clinical Guidance DECEMBER 2017 Federal Bureau of Prisons (BOP) Clinical Guidance is made available to the public for informational purposes only. The BOP does not warrant this guidance for any other purpose, and assumes no responsibility for any injury or damage resulting from the reliance thereof. Proper medical practice necessitates that all cases are evaluated on an individual basis and that treatment decisions are patient- specific. Consult the BOP Health Management Resources Web page to determine the date of the most recent update to this document: http://www.bop.gov/resources/health_care_mngmt.jsp Federal Bureau of Prisons Prevention and Management of Heat-Related Illness Clinical Guidance December 2017 TABLE OF CONTENTS 1. PURPOSE AND OVERVIEW ......................................................................................................................1 2. PATHOPHYSIOLOGY...............................................................................................................................1 3. RISK FACTORS FOR HRI ........................................................................................................................2 4. SYMPTOMS AND SIGNS ..........................................................................................................................3 5. EVALUATION.........................................................................................................................................5 6. TREATMENT..........................................................................................................................................6
    [Show full text]
  • Protecting Workers from Cold Stress
    QUICK CARDTM Protecting Workers from Cold Stress Cold temperatures and increased wind speed (wind chill) cause heat to leave the body more quickly, putting workers at risk of cold stress. Anyone working in the cold may be at risk, e.g., workers in freezers, outdoor agriculture and construction. Common Types of Cold Stress Hypothermia • Normal body temperature (98.6°F) drops to 95°F or less. • Mild Symptoms: alert but shivering. • Moderate to Severe Symptoms: shivering stops; confusion; slurred speech; heart rate/breathing slow; loss of consciousness; death. Frostbite • Body tissues freeze, e.g., hands and feet. Can occur at temperatures above freezing, due to wind chill. May result in amputation. • Symptoms: numbness, reddened skin develops gray/ white patches, feels firm/hard, and may blister. Trench Foot (also known as Immersion Foot) • Non-freezing injury to the foot, caused by lengthy exposure to wet and cold environment. Can occur at air temperature as high as 60°F, if feet are constantly wet. • Symptoms: redness, swelling, numbness, and blisters. Risk Factors • Dressing improperly, wet clothing/skin, and exhaustion. For Prevention, Your Employer Should: • Train you on cold stress hazards and prevention. • Provide engineering controls, e.g., radiant heaters. • Gradually introduce workers to the cold; monitor workers; schedule breaks in warm areas. For more information: U.S. Department of Labor www.osha.gov (800) 321-OSHA (6742) 2014 OSHA 3156-02R QUICK CARDTM How to Protect Yourself and Others • Know the symptoms; monitor yourself and co-workers. • Drink warm, sweetened fluids (no alcohol). • Dress properly: – Layers of loose-fitting, insulating clothes – Insulated jacket, gloves, and a hat (waterproof, if necessary) – Insulated and waterproof boots What to Do When a Worker Suffers from Cold Stress For Hypothermia: • Call 911 immediately in an emergency.
    [Show full text]
  • Altitude Sickness in Nepal Is About 1 in 30,000 Trekkers, Or 2-3 Deaths Per Year
    Shoreland Travax Medical Summary ALTITUDE ILLNESS INTRODUCTION Altitude illness occurs when one ascends more rapidly than the body can adjust ("acclimatize") to the reduced atmospheric pressure and decreased oxygen delivery to the body's cells at the higher altitude. Factors affecting acclimatization include the altitude attained, the rate of ascent, the duration of exposure, genetic predisposition, and certain preexisting conditions. (See "Acclimatization," "Risk," and "Effect of High Altitude on Preexisting Medical Conditions.") Altitude illness is generally divided into 3 syndromes: acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), and high altitude cerebral edema (HACE). See "Syndromes and Symptoms." Symptoms can range from mild to life-threatening. Although mild symptoms have been documented at relatively low altitudes of 1,200- 1,800 m (3,900-5,900 ft), serious syndromes are rarely seen below 2,500-3,000 m (8,200-9,800 ft). While death can occur from the more severe forms of altitude illness, most symptoms can be prevented or minimized by proper acclimatization and/or preventive medications. Risk and prevention strategies vary depending on the type of travel planned: travel to typical tourist destinations at relatively moderate heights or trekking in extreme high altitude situations. See "Risk of Altitude Illness" and "Prevention." ACCLIMATIZATION Acclimatization is a built-in adjustment mechanism that can optimize performance at higher altitudes. If a person ascends more rapidly than the body can adjust, symptoms occur that are referred to as altitude illness. Acclimatization seems to be determined by factors that are not known but may possibly be genetic. Some people adjust very easily to high altitude, while others cannot go above relatively moderate heights of 3,000 m (9,800 ft) without experiencing symptoms.
    [Show full text]
  • Environmental Issues in Sports Medicine Jeremiah Penn, MD Sanford Orthopedics and Sports Medicine Bismarck, ND Lecture Objectives
    Environmental Issues in Sports Medicine Jeremiah Penn, MD Sanford Orthopedics and Sports Medicine Bismarck, ND Lecture Objectives Identify common environmental illnesses Describe prevention of environmental illness Describe treatment for life-threatening and non-emergent environmental illness Mt Everest 29,029 ft above sea level First climbed by Edmund Hillary and Tenzing Norgay on May 29, 1953 Number of summits in 1975: 15 Number of summits in 1995: 83 Number of summits in 2004: 330 Number of summits in 2010: 513 Introduction Outdoor sports are increasing in popularity Participants are becoming more “extreme” Family physicians need to be able to recognize and treat these problems in their patient population Environmental Illness Heat related Illness Cold injury Altitude UV Light Lightning Heat related Illness Heat edema Heat rash Heat syncope Heat cramps Heat exhaustion Heat stroke Human Heat Loss Convection Conduction Evaporation Radiation Chicago Marathon 2007 Wet Bulb Globe Temperature Developed by USMC in 1956 at Parris Island, SC Takes into account temperature, humidity, wind speed, and solar radiation WBGT = 0.7Tw + 0.2Tg + 0.1Td Wet Bulb Globe Temperature Category Temperature (°F) Flag 1 <79.9 None 2 80 – 84.9 Green 3 85 – 87.9 Yellow 4 88 – 89.9 Red 5 ≥90 Black Heat Index Chart Developed by RG Steadman in 1979 Takes into account temperature and relative humidity Much easier to calculate, don’t need special equipment Heat Edema Transient venodilation to facilitate core heat loss Normal body temperature
    [Show full text]
  • Management of Specific Wounds
    7 Management of Specific Wounds Bite Wounds 174 Hygroma 234 Burns 183 Snakebite 239 Inhalation Injuries 195 Brown Recluse Spider Bites 240 Chemical Burns 196 Porcupine Quills 240 Electrical Injuries 197 Lower Extremity Shearing Wounds 243 Radiation Injuries 201 Plate 10: Pipe Insulation Protective Frostbite 204 Device: Elbow 248 Projectile Injuries 205 Plate 11: Pipe Insulation to Protect Explosive Munitions: Ballistic, the Greater Trochanter 250 Blast, and Thermal Injuries 227 Plate 12: Vacuum Drain Impalement Injuries 227 Management of Elbow Pressure Ulcers 228 Hygromas 252 Atlas of Small Animal Wound Management and Reconstructive Surgery, Fourth Edition. Michael M. Pavletic. © 2018 John Wiley & Sons, Inc. Published 2018 by John Wiley & Sons, Inc. Companion website: www.wiley.com/go/pavletic/atlas 173 174 Atlas of Small Animal Wound Management and Reconstructive Surgery BITE WOUNDS to the skin. Wounds may be covered by a thick hair coat and go unrecognized. The skin and underlying Introduction issues can be lacerated, stretched, crushed, and avulsed. Circulatory compromise from the division of vessels and compromise to collateral vascular channels can result in Bite wounds are among the most serious injuries seen in massive tissue necrosis. It may take several days before small animal practice, and can account for 10–15% of all the severity of tissue loss becomes evident. All bites veterinary trauma cases. The canine teeth are designed are considered contaminated wounds: the presence of for tissue penetration, the incisors for grasping, and the bacteria in the face of vascular compromise can precipi- molars/premolars for shearing tissue. The curved canine tate massive infection. teeth of large dogs are capable of deep penetration, whereas the smaller, straighter canine teeth of domestic cats can penetrate directly into tissues, leaving a rela- tively small cutaneous hole.
    [Show full text]
  • Instructor's Guide
    Course Outline pg.1 Heat-Related Illnesses A Risk Easy to Battle Training Hazard Area: Extreme Temperatures Training Topic: Heat-related illnesses: recognition, prevention and treatment Target Industries: Construction and general industries Goal: To train students to recognize, prevent and treat heat-related illnesses resulting in fewer illnesses and deaths from working in extreme heat Learning Objectives: Students will learn: 1) the signs and symptoms of heat stroke, heat exhaustion, heat cramps, hyponatremia and dehydration; 2) how to prevent heat-related illnesses when working in extreme heat indoors or outdoors; 3) how to treat heat-related illnesses; 4) employers and managers – how to develop and implement a heat acclimatization plan and reduce their employees’ risks of developing heat-related illnesses Languages: English and Spanish Course Materials: Table 1 in the Appendix Course Deliver Methods: Informal tabletop flip chart, formal PowerPoint presentations, short videos, worksheets, handouts and game. Can be taught in three separate sections: Recognition, prevention and treatment. Environment: Can be taught indoors or outdoors utilizing different course materials Evaluation Materials: Pre and post assessments, class examinations and class evaluations Class Length: 20 – 60 minutes or longer depending on materials and method used Handouts: Three handouts: NOAA’s National Weather Service Heat Index Chart, NOAA’s National Weather Service Heat Index Chart for Low Humidity and Are You Hydrated? – urine color chart. Promotional Material: Two 8 x 10 flyers in English and Spanish to promote the training classes. Workplace Posters: 1) Three 11 x 17 posters that can also be printed 8 x 10 Topics: Reminding workers to cool down frequently to avoid heat-related illnesses, reminding workers to prevent heat-related illnesses and reminding workers to stay hydrated to prevent heat-related illnesses.
    [Show full text]
  • The Golden Hour of Trauma
    Lecture 4 Feb 27, 2018 THE GOLDEN HOUR OF TRAUMA DAVID KALB, MD MERCY HOSPITAL, COON RAPIDS, MN DR. R ADAMS COWLEY • July 25, 1917 – October 27,1991 • American surgeon • Pioneer in emergency medicine and trauma care • “Father of Trauma Medicine” • Founder of U.S’s first trauma center at U of MD, 1958 • Leader in use of helicopters for med evac of civilians, from 1969 • Founded the nation’s first statewide EMS system in 1972 ©AllinaHealthSystem Lecture 4 Feb 27, 2018 DR. R ADAMS COWLEY GOLDEN HOUR • Coined by Dr. Cowley • “There is a golden hour between life and death. If you are critically injured you have less than 60 minutes to survive. You might not die right then; it may be three days or two weeks later – but something has happened to your body that is irreparable.” (from U of MD website) • “the first hour after injury will largely determine a critically-injured person’s chances for survival” (MD State Medical Journal 1975) ©AllinaHealthSystem Lecture 4 Feb 27, 2018 GOLDEN HOUR GOLDEN HOUR ©AllinaHealthSystem Lecture 4 Feb 27, 2018 •What does the data show?? EVIDENCE IN FAVOR OF THE GOLDEN HOUR • 1993 Journal of Trauma Sampalis et al • Total prehospital time over 60 minutes was associated with significant increase in odds of mortality • 1999 Journal of Trauma Sampalis et al • Reduced prehospital time associated with reduced odds of dying • When outcomes controlled for • Severity of injury • Age of population ©AllinaHealthSystem Lecture 4 Feb 27, 2018 EVIDENCE IN FAVOR OF THE GOLDEN HOUR • Acad Emerg Med 2002 Blackwell et al • EMS response
    [Show full text]
  • Summary of Product Characteristics
    Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Salbutamol CFC-Free Inhaler 100 micrograms per metered dose, pressurised inhalation, suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One metered dose contains 100 micrograms of salbutamol (equivalent to 120 micrograms of salbutamol sulphate). This is equivalent to a delivered dose of 90 micrograms of salbutamol (equivalent to 108 micrograms of salbutamol sulphate). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pressurised inhalation suspension Pressurised inhalation suspension supplied in an aluminium canister with a metering valve and a plastic actuator and dust cap. 4 CLINICAL PARTICULARS 4.1 Therapeutic Indications Salbutamol CFC-Free Inhaler is indicated in adults, adolescents and children. For babies and children under 4 years of age, see sections 4.2 and 5.1. Salbutamol CFC-Free Inhaler is indicated for the relief and prevention of bronchial asthma and conditions associated with reversible airways obstruction. Salbutamol CFC-Free Inhaler can be used as relief medication in the management of mild, moderate or severe asthma, provided that its use does not delay the introduction and use of regular inhaled corticosteroid therapy, where necessary. 4.2 Posology and method of administration Salbutamol CFC-Free Inhaler is for oral inhalation use only. Posology Adults (including the elderly) and adolescents (children 12 years and over): For the relief of acute bronchospasm, one inhalation (100 micrograms) increasing to two inhalations (200 micrograms), if necessary. To prevent allergen- or exercise-induced symptoms, two inhalations (200 micrograms) should be taken 10-15 minutes before challenge. Maximum daily dose: two inhalations (200 micrograms) up to four times a day.
    [Show full text]
  • Occupational Exposure to Heat and Hot Environments
    Criteria for a Recommended Standard Occupational Exposure to Heat and Hot Environments DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Cover photo by Thinkstock© Criteria for a Recommended Standard Occupational Exposure to Heat and Hot Environments Revised Criteria 2016 Brenda Jacklitsch, MS; W. Jon Williams, PhD; Kristin Musolin, DO, MS; Aitor Coca, PhD; Jung-Hyun Kim, PhD; Nina Turner, PhD DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health This document is in the public domain and may be freely copied or reprinted. Disclaimer Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health (NIOSH). In addition, citations of websites external to NIOSH do not constitute NIOSH endorsement of the sponsoring organizations or their programs or products. Furthermore, NIOSH is not responsible for the content of these websites. Ordering Information This document is in the public domain and may be freely copied or reprinted. To receive NIOSH documents or other information about occupational safety and health topics, contact NIOSH at Telephone: 1-800-CDC-INFO (1-800-232-4636) TTY: 1-888-232-6348 E-mail: [email protected] or visit the NIOSH website at www.cdc.gov/niosh. For a monthly update on news at NIOSH, subscribe to NIOSH eNews by visiting www.cdc.gov/ niosh/eNews. Suggested Citation NIOSH [2016]. NIOSH criteria for a recommended standard: occupational exposure to heat and hot environments. By Jacklitsch B, Williams WJ, Musolin K, Coca A, Kim J-H, Turner N.
    [Show full text]
  • Deadly High Altitude Pulmonary Disorders: Acute Mountain Sickness
    Research Article Int J Pul & Res Sci Volume 1 Issue 1 - April 2016 Copyright © All rights are reserved by Michael Obrowski DOI : 10.19080/IJOPRS.2016.01.555553 Deadly High Altitude Pulmonary Disorders: Acute Mountain Sickness (AMS); High Altitude Pulmonary Edema (HAPE) and High Altitude Cerebral Edema (HACE): A Clinical Review Michael Obrowski1* and Stephanie Obrowski2 1Doctor of Medicine (M.D. – 2000); Assistant Professor of Anatomy; CEO, Chief Physician and Surgeon of Wilderness Physicians, European Union 2Doctor of Medicine (M.D. – 2019); Medical University of Łódź; President of Wilderness Physicians, European Union Submission: January 26, 2016; Published: April 15, 2016 *Corresponding author: Michael Obrowski, M.D., Doctor of Medicine (M.D. – 2000); Assistant Professor of Anatomy; CEO, Chief Physician and Surgeon of Wilderness Physicians, European Union, 43C Żeligowskiego Street, #45, Łódź, Poland 90-644, Email: Abstract Acute Mountain Sickness (AMS); High Altitude Pulmonary Edema (HAPE) and High Altitude Cerebral Edema (HACE). These three disorders, withMountain relatively Sickness, unimportant also smallcalled variationsHigh Altitude seen Sickness, in some isPulmonology specifically aTextbooks, triad of different because disorders, these are inso orderserious, of increasingthey are all seriousness: potentially deadly pulmonary disorders and we will discuss these three major, deadly disorders. Each one, starting with AMS, can progress rapidly to HAPE and then HACE. The two authors of this article have over half a century of high altitude mountaineering experience. They have also alsohad anddisaster still domedicine. have, for Since the lastspring twenty is rapidly years, approaching an NGO, Non-Profit and many Medical “weekend Organization backpackers” (Wilderness will start Physicians going into www.wildernessphysicians.
    [Show full text]
  • Supporting Information a Analysed Substances
    Electronic Supplementary Material (ESI) for Analyst. This journal is © The Royal Society of Chemistry 2020 List of contents: Tab. A1 Detailed list and classification of analysed substances. Tab. A2 List of selected MS/MS parameters for the analytes. Tab. A1 Detailed list and classification of analysed substances. drug of therapeutic doping agent analytical standard substance abuse drug (WADA class)* supplier (+\-)-amphetamine ✓ ✓ S6 stimulants LGC (+\-)-methamphetamine ✓ S6 stimulants LGC (+\-)-3,4-methylenedioxymethamphetamine (MDMA) ✓ S6 stimulants LGC methylhexanamine (4-methylhexan-2-amine, DMAA) S6 stimulants Sigma cocaine ✓ ✓ S6 stimulants LGC methylphenidate ✓ ✓ S6 stimulants LGC nikethamide (N,N-diethylnicotinamide) ✓ S6 stimulants Aldrich strychnine S6 stimulants Sigma (-)-Δ9-tetrahydrocannabinol (THC) ✓ ✓ S8 cannabinoids LGC (-)-11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH) S8 cannabinoids LGC morphine ✓ ✓ S7 narcotics LGC heroin (diacetylmorphine) ✓ ✓ S7 narcotics LGC hydrocodone ✓ ✓ Cerillant® oxycodone ✓ ✓ S7 narcotics LGC (+\-)-methadone ✓ ✓ S7 narcotics Cerillant® buprenorphine ✓ ✓ S7 narcotics Cerillant® fentanyl ✓ ✓ S7 narcotics LGC ketamine ✓ ✓ LGC phencyclidine (PCP) ✓ S0 non-approved substances LGC lysergic acid diethylamide (LSD) ✓ S0 non-approved substances LGC psilocybin ✓ S0 non-approved substances Cerillant® alprazolam ✓ ✓ LGC clonazepam ✓ ✓ Cerillant® flunitrazepam ✓ ✓ LGC zolpidem ✓ ✓ LGC VETRANAL™ boldenone (Δ1-testosterone / 1-dehydrotestosterone) ✓ S1 anabolic agents (Sigma-Aldrich)
    [Show full text]
  • Comparison of Health and Performance Risk for Accelerated Mars Mission Scenarios
    NASA/TM-20210009779 Comparison of Health and Performance Risk for Accelerated Mars Mission Scenarios Erik Antonsen MD, PhD Baylor College of Medicine NASA Johnson Space Center, Houston, TX Mary Van Baalen, PhD; NASA Johnson Space Center, Houston, TX Integrated Medical Model Team Space Radiation Analysis Group Binaifer Kadwa, MS Lori Chappell, MS NASA Johnson Space Center, Houston, TX KBR NASA Johnson Space Center, Houston, TX Lynn Boley, RN, MS KBR Edward Semones, MS NASA Johnson Space Center, Houston, TX NASA Johnson Space Center, Houston, TX John Arellano, PhD Space Radiation Element MEI Technologies NASA Johnson Space Center, Houston, TX S. Robin Elgart, PhD University of Houston Eric Kerstman, MD NASA Johnson Space Center, Houston, TX University of Texas Medical Branch NASA Johnson Space Center, Houston, TX National Aeronautics and Space Administration Lyndon B. Johnson Space Center Houston, Texas 77058 February 2021 NASA STI Program…in Profile Since its founding, NASA has been dedicated to the CONFERENCE PUBLICATION. advancement of aeronautics and space science. The Collected papers from scientific and NASA scientific and technical information (STI) technical conferences, symposia, seminars program plays a key part in helping NASA or other meetings sponsored or co- maintain this important role. sponsored by NASA. The NASA STI program operates under the auspices of the Agency Chief Information Officer. SPECIAL PUBLICATION. Scientific, It collects, organizes, provides for archiving, and technical, or historical information from disseminates NASA’s STI. The NASA STI NASA programs, projects, and missions, program provides access to the NTRS Registered often concerned with subjects having and its public interface, the NASA Technical substantial public interest.
    [Show full text]